Trimethoprim-sulphamethoxazole and folate metabolism.
D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001681:Biological Assay; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D005260:Female; D005492:Folic Acid / Q000097:blood*; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007780:Lacticaseibacillus casei / Q000378:metabolism; D008297:Male; D010376:Pediococcus / Q000378:metabolism; D011743:Pyrimidines / Q000627:therapeutic use*; D011817:Rabbits; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D014295:Trimethoprim / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D005492:Folic Acid; D014295:Trimethoprim; D013762:Tetrahydrofolate Dehydrogenase; D013420:Sulfamethoxazole